HopeStage
Back to all studies
CompletedNCT00001146

Omega-3 supplements for mood symptoms in bipolarity

About this title

Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial

Read the official source — NCT00001146
Medication studyUnited States
The study in practice

Understand this study

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 1999
Recruitment status
Completed
Enrollment listed in the registry
240
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT00001146
Official title
Show the full official title

Omega-3 Fatty Acids in the Treatment of Major Depression and Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Ethyl Eicosapentaenoic Acid and OmegaBrite.

Want to explore more studies?

Explore studies